A Johnson & Johnson internal study found that recalled DePuy ASR hip replacements have a 37 percent failure rate after five years of use, according to a recent New York Times article. The Rottenstein Law Group monitors this situation with concern.
The internal study suggests that more of the 37,000 DePuy hip implant recipients in the United States than expected will have to undergo correction and replacement surgeries in the coming years, according to the Times article based on documents unsealed in a DePuy hip lawsuit in Los Angeles Superior Court (In re: Loren Kransky and Sheryl Kransky v. DePuy, Inc., et al., BC456086, Los Angeles Superior Court), the first DePuy hip trial in the country to proceed beyond jury selection.
“This is more evidence of Johnson & Johnson’s breach of consumer trust,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “DePuy hip replacement recipients thought they were getting relief from hip problems, not more problems.”
Read more : DePuy Hip Recall Lawsuit Update: Rottenstein Law Group Concerned by J&J Admission of Increased Hip Implant Failure Rates